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AbstrACt
Introduction Neck pain is a common musculoskeletal 
disorder worldwide. It can result in significant disability 
and impaired quality of life. More than 50% of patients 
with neck pain still report symptoms 1 year later despite 
receiving different forms of non-pharmacological 
and pharmacological treatment. Identifying patient 
characteristics that are modifiable or predict recovery 
and non-recovery for an individual patient might identify 
ways of improving outcomes. This systematic review aims 
to comprehensively summarise the existing evidence 
regarding baseline patient characteristics associated with 
recovery and non-recovery, as defined by measures of 
pain intensity, disability and global perceived improvement.
Methods and analysis Six electronic databases, PubMed, 
CINAHL, PEDro Database, EMBASE, Cochrane Library 
and Web of Science, will be searched, with terms related 
to the review question such as neck pain, prognostic or 
predictive research, from inception to 28 September of 
2018. Studies will be included if they have investigated an 
association between patient characteristics and outcomes, 
with at least one follow-up time point. Two independent 
reviewers will screen the titles and abstracts followed 
by a full-text review to assess papers regarding their 
eligibility. Data from included papers will be extracted 
using standardised forms, including study and participants’ 
characteristics, outcomes, prognostic factors and effect 
size of the association. The risk of bias of each study will 
be assessed using the Quality in Prognostic Studies tool. 
A narrative synthesis will be conducted considering the 
strength, consistency of results and the methodological 
quality.
Ethics and dissemination This systematic review 
does not require ethical approval. The results will be 
disseminated through publication in a peer-review journal, 
as a chapter of a doctoral thesis and through presentations 
at national and international conferences.
PrOsPErO registration number CRD42018091183.
IntrOduCtIOn 
rationale
Neck pain is one of the most common muscu-
loskeletal disorders worldwide and may have a 
significant impact on function and quality of 
life.1–4 In the general population, 30%–50% 
of adults will experience an episode of neck 
pain at least once in their lifetime,5 and the 
prevalence peaks in adults between 40 and 45 
years of age.2 According to the Global Burden 
of Disease Study 2016, neck pain is the second 
most common musculoskeletal condition 
after low back pain.4 Disability-adjusted life-
years increased from 17 million (95% CI 11.4 
million to 23.7 million) in 1990 to 24 million 
(95% CI 16.2 million to 33.4 million) in 2006, 
and increased again to 29 million (95% CI 
19.5 million to 40.5 million) in 2016.4 
Of those who experience acute neck pain, 
up to 50%–85% will report pain 1–5 years 
later.6 Neck pain is also often associated with 
other complaints such as low back pain and 
headache, and with poorer self-rated health.7 
Neck pain presents an economic burden for 
society since it may result in extended periods 
of sick-leave from work and high use of health 
services.8
Most often a specific cause of neck pain 
symptoms cannot be identified and the label 
strengths and limitations of this study
 ► The planned systematic review aims to compre-
hensively synthesise the available evidence about 
prognostic factors for recovery and non-recovery in 
patients with non-specific neck pain.
 ► This protocol has been developed following the guid-
ance of the Preferred Reporting Items for Systematic 
Review and Meta-analyses Protocols and has 
been registered with the Prospective Register of 
Systematic Reviews.
 ► Heterogeneity of the definition of recovery or non-re-
covery in terms of pain intensity, disability or global 
perceived improvement, may hamper the consistent 
conclusions.
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of non-specific neck pain is given, defined as pain in the 
cervical region without an identifiable specific anatomo-
pathological diagnosis.9–11 Patients with neck pain are 
commonly referred for non-pharmacological or pharma-
cological treatment, with considerable heterogeneity of 
outcomes and recovery rates.12–16
The literature on recovery and non-recovery from 
neck pain has shown associations with clinical, sociode-
mographic and psychosocial patient characteristics, and 
some authors suggest that these prognostic factors are 
the key to explaining the outcomes achieved in these 
patients.17 18 Factors such as older age, female gender, 
the presence of low back pain, past history of neck symp-
toms and previous trauma have been associated with less 
favourable outcomes in terms of disability, pain intensity 
or global perceived improvement.11 19–22
The knowledge of these prognostic factors may help 
clinicians to better distinguish between patients with a 
good versus less favourable prognosis, leading to provi-
sion of better advice about likely outcomes and better 
management decisions.17 23
Despite the increasing number of primary studies 
published in recent years, the last systematic review on 
prognostic factors in patients with neck pain was published 
in 2009.11 19–21 24 This and other systematic reviews have 
examined risk factors for developing neck pain and prog-
nostic factors for course and recurrence, but they have 
combined populations with traumatic and non-traumatic 
causes of neck pain and none of them has focused on 
prognosis for recovery or non-recovery.11 19–21 24
Given its high rate of prevalence, the identification 
of prognostic factors for recovery and non-recovery in 
patients with non-specific neck pain is relevant for effec-
tive patient management. However, to our knowledge, 
no published systematic review has yet identified and 
synthesised the available evidence concerning prognostic 
factors for recovery and non-recovery, regarding pain 
intensity, disability and global perceived improvement, in 
adult patients with non-specific neck pain.
Objectives
The aim of this review is to identify, assess and synthesise 
the available evidence about prognostic factors for short-
term and long-term recovery and non-recovery, in terms 
of pain intensity, disability and global perceived improve-
ment in patients with non-specific neck pain.
MEthOds And AnAlysIs
This review protocol is registered with the International 
Prospective Register of Systematic Reviews by the Centre 
for Reviews and Dissemination at the University of York, 
with the number CRD42018091183.25 The protocol and 
completed review will be reported following the guid-
ance of the Preferred Reporting Items for Systematic 
Review and Meta-analyses Protocols,26 and the Preferred 
Reporting Items for Systematic Review and Meta-analyses 
(PRISMA),25 respectively.
Eligibility criteria
Studies will be selected according to the criteria outlined 
below.
Participants and settings
Studies will be included in this review if they investigate 
adults (aged over 18 years of age) with non-specific neck 
pain, defined as pain in the cervical region without a 
specific anatomopathological diagnosis.9–11 The studies 
that include people with specific causes of neck pain (eg, 
nerve root compression, trauma, malignancy, infection), 
inflammatory arthritis (eg, rheumatoid arthritis, spon-
dyloarthritis) or neurological diseases (eg, multiple scle-
rosis) will be excluded. No restrictions will be applied to 
the setting.
Exposure and outcome measures
This systematic review seeks to identify demographic, 
clinical and psychosocial factors assessed at baseline that 
examine the association with recovery or non-recovery in 
patients with non-specific neck pain.
The definition of demographic, clinical and psycho-
social factors was established according to a theoretical 
framework, based on the following constructs:
Demographic factors: ‘Socioeconomic characteristics 
of a population expressed statistically, such as age, sex, 
education level, income level, marital status, occupation, 
religion, birth rate, death rate, average size of a family, 
average age at marriage’.27
Clinical condition: signs and symptoms of the disease or 
clinical condition, presented or described by the patient 
or found in clinical evaluation, defined in Medical Subject 
Headings (MeSH) terms as ‘disease attribute—clinical 
characteristics of disease or illness’.
Psychosocial factors: ‘Social factors include general factors 
at the level of human society concerned with social struc-
ture and social processes that impinge on the individual. 
Psychological factors include individual-level processes 
and meanings that influence mental states’.28
Study participants might or might not be treated. If 
treated, the interventions may include any management 
and care of any duration, with an explicit description 
of treatment (eg, medication, exercise, manual therapy, 
acupuncture, surgery, etc).
The outcome of this systematic review is recovery and 
non-recovery regarding disability, pain intensity and global 
perceived improvement. The definition of recovery/
non-recovery presented by the authors of original articles 
(eg, based on definition of ‘recovery’ or ‘complete remis-
sion’ or ‘functional recovery’ or ‘non-recovery’) will be 
accepted, if they are determined by at least one of the 
following outcome domains: disability, pain intensity and 
global perceived improvement.
Any recovery/non-recovery criterion presented by the 
authors of the original studies will be accepted. It can 
be based on a cut-off point (eg, recovery in disability: 
decrease at least 27% in Neck Disability Index; score 
higher than 5 in a Global Recovery Scale), established 
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by authors, or based on a recovery continuum. In the 
absence of a clear recovery/non-recovery criterion, the 
studies will be excluded.
All outcome measures of disability, pain intensity and 
global perceived improvement will be accepted if they 
correspond to validated instruments (appropriate for 
culture and language), specific for people with neck pain, 
and with at least one follow-up time point. Where several 
measures were used, all the measures will be extracted 
and classified according to the domain.
Outcomes will be considered at two time points from 
baseline defined as ≤6 months and >6 months. If multiple 
data of disability, pain intensity or global perceived 
improvement are provided, data close to these time 
points will be prioritised.
Study designs
Eligible studies will be prospective cohort studies or 
randomised controlled trials (RCTs) with prognostic 
factor analysis, published in peer-reviewed journals. RCTs 
will only be included if information regarding prognostic 
factors for recovery and non-recovery are available in the 
published report. The studies will have to identify prog-
nostic factors at baseline and report a statistical association 
(or lack of association) with an outcome (disability, pain 
intensity and/or global perceived improvement). Studies 
including people with pain elsewhere will be included 
provided if the data for the participants with non-specific 
neck pain are reported separately. Cross-sectional studies, 
case series, case reports, case-control studies, systematic 
reviews, conference proceedings and Masters or PhD 
theses will be excluded.
Language and time frame
No language or geographical restriction will be applied. 
The search in each database will be performed from 
inception to 28 September 2018.
Information sources and search strategy
Searches will be conducted in six electronic databases: 
PubMed, CINAHL (via EBSCO), PEDro Database; 
EMBASE (via Elsevier); Cochrane Library (via Wiley 
Online Library) and Web of Science (via Clarivate 
Analytics). Additionally, hand searches of the reference 
lists of all included studies and previously published 
systematic reviews of prognostic factors for non-specific 
neck pain will be conducted to ensure completeness of 
the search.11 19 21
The search strategy will be developed in consulta-
tion with a medical librarian with expertise in system-
atic review searching. A variety of terms related to key 
subject areas of the review question such as neck pain, 
prognostic or predictive research will be used. Keywords 
or database-specific subject headings (eg, MeSH) and 
the Boolean operators ‘OR’ and ‘AND’ will be used to 
combine the search terms. The search terms will be 
adjusted to the specificities of the different databases. A 
draft of the PubMed search strategy is included in table 1.
study selection
All potentially eligible articles will be retrieved and organ-
ised in the Mendeley reference manager software and 
duplicate publications will be deleted. Two independent 
reviewers will screen the titles and abstracts identified in 
the search to identify potentially eligible studies and will 
perform full-text review of all those identified to deter-
mine inclusion. Reasons for exclusion will be documented 
in tabular format. Any disagreements between reviewers 
will be resolved by consensus or by consulting a third 
independent reviewer if consensus cannot be reached.
The PRISMA flow diagram will document included 
and excluded studies with the reasons for exclusion.26 29 
Reviewers will not be blind to the study authors, institu-
tions or journals.
data extraction
Two independent reviewers will extract relevant data 
from each selected study, using a piloted standardised 
data extraction form. To ensure consistency of data 
extraction, the form will be tested on a sample of five 
studies, prior to the main data extraction. Any discrep-
ancies in data extraction will be resolved by consensus or 
discussion with a third reviewer if needed. Reviewers will 
not be blind to the study authors, institutions or journals.
The extracted data will consist of:
1. Study identification (authors, year of publication, vol-
ume, issue and pages);
2. Study characteristics (study setting, study design, sam-
ple size, type of intervention, follow-up length, drop-
out rate, source of funding and country of origin);
Table 1 Draft of search strategy in PubMed
Search strategy in PubMed database
No Search items
1 ‘neck pain’[MeSH Terms]
2 ‘neck’[All Fields] AND ‘pain’[All Fields]
3 ‘neck pain’[All Fields]
4 1 or 2 or 3
5 predictor[All Fields]
6 predictors[All Fields]
7 Prognostic OR Prognosis[All Fields] OR 
‘Prognosis’[Mesh]
8 5 or 6 or 7
9 4 and 8
10 ‘therapy’[Subheading]
11 ‘therapy’[All Fields]
12 ‘treatment’[All Fields]
13 ‘therapeutics’[MeSH Terms]
14 ‘therapeutics’[All Fields]
15 ‘intervention’[All Fields]
16 10 or 11 or 12 or 13 or 14 or 15
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3. Participants’ characteristics (age, gender, duration of 
neck pain, pain intensity, disability);
4. Prognostic factors (any demographic, clinical and psy-
chosocial factors defined according to a theoretical 
framework described in ‘Exposure and outcome mea-
sures’ section);
5. Outcomes (any measure of recovery or non-recov-
ery in terms of pain intensity, disability and global 
perceived improvement, the cut-off point or the 
statistical analysis of clinical improvement to define 
recovery/non-recovery and rate of recovery, when 
available);
6. Effect size (measures of unadjusted and adjusted asso-
ciations (with description of variables adjusted) report-
ed between prognostic factors and outcomes).
If the studies have assessed multiple outcomes, only 
the information that is relevant to this systematic review 
research question will be extracted. If there are missing 
data about study characteristics, methods or measures of 
association, the study authors will be contacted and asked 
to provide these data with a maximum of three email 
attempts in a 2-month period.
If the same data have been reported in multiple study 
publications, the duplicated data will be presented only 
one time, to minimise the overrating of any prognostic 
factors investigated in the same sample.
Assessment of risk of bias
The risk of bias of the included studies will be assessed 
through the Quality in Prognostic Studies (QUIPS) tool.30 
This tool addresses six potential domains of bias: study 
participation, study attrition, prognostic factor measure-
ment, outcome measurement, study confounding and 
statistical analysis and reporting.
Two independent reviewers will assess the risk of bias 
of each included study, following training in risk of bias 
assessment. The training will consist of application of the 
QUIPS tool to three articles, with either low, moderate 
or high risk of bias, investigating prognostic factors for 
recovery or non-recovery from low back pain. Inter-
rater agreement for each domain will be evaluated by 
percentage of agreement (calculated as the number 
of agreement domains divided by the total number 
of domains). If <90% agreement is observed, a second 
training programme will be conducted.
The results of the risk of bias assessment for each 
included study will be presented in tabular format by each 
domain and overall. Reviewers will first assess the relevant 
risk of bias items in each domain and then produce an 
overall judgement based on these ratings. Each domain 
and overall risk of bias will be categorised as low, moderate 
or high risk of bias. An overall judgement of low risk of 
bias will require all six bias domains to be rated as low 
risk of bias. Any disagreements between reviewers will be 
resolved through discussion or consultation with a third 
reviewer if required.
data synthesis
A formal meta-analysis is not planned for this systematic 
review as the populations, type of treatment received, defi-
nitions or prognostic factors, outcomes and methods/
tools are anticipated to be too heterogeneous.31 32 Conse-
quently, a narrative synthesis will be conducted taking 
into account risk of bias and the strength and consistency 
of significant associations.
We will extract and report all unadjusted and adjusted 
measures of association from included studies. Associations 
with outcome will be defined as a significant (p<0.2) univari-
able association, a significant (p<0.05) adjusted association 
(multivariable) or a significant (p<0.05) association in other 
predictive analysis (linear or multiple regression).
Effect sizes will be represented as an OR or relative risk 
(RR) and considered as significant when the 95% CIs do 
not include 1, or as a coefficient of determination (R2) 
and beta-coefficient (b) when the 95% CIs do not include 
0. Results will be analysed using the levels of evidence 
proposed by Furlan et al33:
A. strong evidence, defined as consistent (>75%) find-
ings among multiple (≥2) high-quality studies;
B. moderate evidence, defined as findings in one 
high-quality study and consistent (>75%) findings 
in ≥2 low-quality studies;
C. limited evidence, that is, findings in one high-quality 
study or consistent findings in ≥3 low-quality studies;
D. conflicting or inconclusive evidence, that is, <75% of 
the studies reported consistent findings or the results 
were only based on one study.
To simplify the data presentation, the prognostic factors 
will be categorised into three main domains: demo-
graphic, clinical and psychosocial factors, according to 
the theoretical framework defined a priori. A tabular 
form for each category will be made with the discrimina-
tion of all the factors, with data of outcomes, effect size as 
well as the level of evidence.
Additionally, homogeneous subgroups will be defined 
according to pain duration (acute/subacute (0–12 weeks) 
and chronic (>12 weeks)), type of treatment (medication, 
exercise, manual therapy, acupuncture, surgery, etc) and 
outcome measurement (pain, functional limitations, 
global perceived improvement/recovery). Should we 
decide on any other categorisation, we will note this and 
provide a rationale.
To assess the robustness of our evidence synthesis, a 
sensitivity analysis will be carried out to examine the influ-
ence of the risk of bias whenever possible.
Patient and public involvement
This article reports a protocol of the systematic review. 
Therefore, patients and or public were not involved and 
individual patient data will not be collected.
EthICs And dIssEMInAtIOn
A comprehensive systematic review to synthesise the 
available evidence about prognostic factors for recovery 
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and non-recovery in patients with non-specific neck pain 
is needed considering the multiplicity of the clinical, 
sociodemographic and psychosocial patient characteris-
tics identified in the literature. Moreover, and given the 
expected clinical and/or methodological heterogeneity 
in the individual studies that will be included in this 
review, the review aims to provide possible directions 
for standardisation of participants, outcome measures, 
cut-off points and follow-up time points in future obser-
vational studies.
Formal ethical approval is not required, as individual 
patient data will not be collected. The results will be 
disseminated through a peer-reviewed publication and 
conference presentations and included in a chapter of a 
Doctoral thesis.
AMEndMEnts
If there are any amendments, we will register the date, 
describe the change and the rationale. Changes will not 
be incorporated into the protocol but in the PROSPERO 
register and will be identified in the systematic review.
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